Thalassaemia: vizsgálatok itt: Dél-Korea
1 of 1 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia
- Where
- Seoul
- Életkor
- 19 év and over
- People
- 104
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06073860